Literature DB >> 9467855

Critical telomere shortening regulated by the ataxia-telangiectasia gene acts as a DNA damage signal leading to activation of p53 protein and limited life-span of human diploid fibroblasts. A review.

H Vaziri1.   

Abstract

Somatic cells undergo a limited number of doublings in culture and enter an irreversible block in the G1 and G2/M phase of the cell cycle termed "senescence". Telomere shortening presumably as a consequence of the end-replication problem has been proposed to act as a mitotic clock eventually leading to cellular senescence. Several models have been proposed to explain how telomere shortening can lead to cellular senescence. We proposed previously that telomere shortening may eventually lead to formation of dicentric chromosomes which on subsequent breakage activate a DNA damage response pathway involving the p53 protein. Hence we proposed that the telomere shortening signal is perceived by the cell as DNA damage. Recently we have obtained experimental evidence that the p53 protein is activated posttranslationally in human fibroblasts which undergo telomere shortening and subsequent senescence in culture. In this paper we also show that the increased activity of p53 protein coincides with formation of dicentric chromosomes and senescence. Also, we have previously found that an increase in the level of the down stream target of p53 protein, p21WAF1/SD11/C1P1, is dependent on both p53 and p300 proteins. We have also shown that fibroblasts obtained from individuals with Ataxia Telangiectasia lose telomeric DNA at an accelerated rate, activate p53 protein, and undergo premature senescence in culture. These results suggest that the ataxia-telangiectasia gene (ATM) and p53 are involved in surveillance and regulation of telomeric DNA. Once a critical length of telomeric DNA is reached. ATM and p53 sense and relay this signal to the cell cycle leading to senescence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9467855

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  13 in total

1.  MEC3, MEC1, and DDC2 are essential components of a telomere checkpoint pathway required for cell cycle arrest during senescence in Saccharomyces cerevisiae.

Authors:  Shinichiro Enomoto; Lynn Glowczewski; Judith Berman
Journal:  Mol Biol Cell       Date:  2002-08       Impact factor: 4.138

2.  Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.

Authors:  Mindy K Graham; Jiyoung Kim; Joseph Da; Jacqueline A Brosnan-Cashman; Anthony Rizzo; Javier A Baena Del Valle; Lionel Chia; Michael Rubenstein; Christine Davis; Qizhi Zheng; Leslie Cope; Michael Considine; Michael C Haffner; Angelo M De Marzo; Alan K Meeker; Christopher M Heaphy
Journal:  Mol Cancer Res       Date:  2019-10-14       Impact factor: 5.852

3.  Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.

Authors:  Christopher M Heaphy; Andrea P Subhawong; Seung-Mo Hong; Michael G Goggins; Elizabeth A Montgomery; Edward Gabrielson; George J Netto; Jonathan I Epstein; Tamara L Lotan; William H Westra; Ie-Ming Shih; Christine A Iacobuzio-Donahue; Anirban Maitra; Qing K Li; Charles G Eberhart; Janis M Taube; Dinesh Rakheja; Robert J Kurman; T C Wu; Richard B Roden; Pedram Argani; Angelo M De Marzo; Luigi Terracciano; Michael Torbenson; Alan K Meeker
Journal:  Am J Pathol       Date:  2011-09-01       Impact factor: 4.307

4.  Genetic interactions between ATM and the nonhomologous end-joining factors in genomic stability and development.

Authors:  J Sekiguchi; D O Ferguson; H T Chen; E M Yang; J Earle; K Frank; S Whitlow; Y Gu; Y Xu; A Nussenzweig; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

5.  Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes.

Authors:  Christopher M Heaphy; Andrea Proctor Subhawong; Amy L Gross; Yuko Konishi; Nina Kouprina; Pedram Argani; Kala Visvanathan; Alan K Meeker
Journal:  Mod Pathol       Date:  2010-11-05       Impact factor: 7.842

6.  Low p16INK4a Expression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone.

Authors:  Mindy Kim Graham; Lorenzo Principessa; Lizamma Antony; Alan K Meeker; John T Isaacs
Journal:  Prostate       Date:  2016-11-08       Impact factor: 4.104

7.  Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.

Authors:  Christopher M Heaphy; Michael C Haffner; Mindy K Graham; David Lim; Christine Davis; Eva Corey; Jonathan I Epstein; Mario A Eisenberger; Hao Wang; Angelo M De Marzo; Alan K Meeker; Tamara L Lotan
Journal:  Hum Pathol       Date:  2020-05-07       Impact factor: 3.466

8.  Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer.

Authors:  Eric G Treat; Christopher M Heaphy; Larry W Massie; Marco Bisoffi; Anthony Y Smith; Michael S Davis; Jeffrey K Griffith
Journal:  Urology       Date:  2009-07-16       Impact factor: 2.649

9.  Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.

Authors:  Christopher M Heaphy; Ghil Suk Yoon; Sarah B Peskoe; Corinne E Joshu; Thomas K Lee; Edward Giovannucci; Lorelei A Mucci; Stacey A Kenfield; Meir J Stampfer; Jessica L Hicks; Angelo M De Marzo; Elizabeth A Platz; Alan K Meeker
Journal:  Cancer Discov       Date:  2013-06-18       Impact factor: 39.397

10.  Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype.

Authors:  Sam Nayler; Magtouf Gatei; Sergei Kozlov; Richard Gatti; Jessica C Mar; Christine A Wells; Martin Lavin; Ernst Wolvetang
Journal:  Stem Cells Transl Med       Date:  2012-06-28       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.